reference/35135797

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35135797

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	2103
issn	1755-5949 1755-5930
issueIdentifier	12
pageRange	2090-2103
publicationName	CNS Neuroscience & Therapeutics
startingPage	2090
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a71960533e57bbfecb38e66869a95032 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_56fd99d1c459b4b94d2aaea8fcd0f89f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_571b65498f3e26c4d9ceef431e046760 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ad342efccce6a32dd723af59e8a7a00f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Fan W, Wang D, Li G, Xu J, Ren C, Sun Z, Wang Z, Ma W, Zhao Z, Bao Z, Jiang T, Zhang Y. A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma. CNS Neurosci Ther. 2022 Dec;28(12):2090–103. PMID: 35985661; PMCID: PMC9627384.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_556786cf3e879dfb75238be75d54d7df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb5541089d1ff756573c9c086698532a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5229-3736 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7008-6351 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e22742b86369b13b2f9de640721b3fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34040d958784e998f2f476fcc4b392d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1564-4584 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7613-6188 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06ef11c9c0dcbb9e418fecd02c7ab442 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e09b28842bfe3a092b1f6bca9bd14214 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daeba40cd0e3266beb94375f431052a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae9a610478b5c21bcaeaac258bdf8eac
date	2022-08-19^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC9627384 https://doi.org/10.1111/cns.13944 https://pubmed.ncbi.nlm.nih.gov/35985661
isPartOf	https://portal.issn.org/resource/ISSN/1755-5949 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34519 https://portal.issn.org/resource/ISSN/1755-5930
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma
discusses	http://id.nlm.nih.gov/mesh/M0028294
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005910Q000235 http://id.nlm.nih.gov/mesh/D005909 http://id.nlm.nih.gov/mesh/D001932Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D059016 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018925 http://id.nlm.nih.gov/mesh/D011379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7839 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8d05c5ff041dba232d911c48d686a255 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b1179ffc80d13c0812f905e9c7e285da http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2ab58218e66c44abfda571265052c5d3 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0c90ba0ef2ae7b4aa70fe1b374a2ce http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8642d21b3cea0778947b7ceb6a1487e3 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7e4d19766b8958e96da36c9f9cf8a76 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_dde3bf4279d96ccee1d6f267117b55e4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1466772cb1e0216a97b90e84b70acebf

Showing number of triples: 1 to 58 of 58.